SESSION CODE:
[PL] Plenary Lecture, [SS] Scientific Symposium, [JS] Joint Symposium, [SP] Special Symposium, [ES] Education Session,
[MDCD] Multi-Disciplinary Case Discussion, [LS] Luncheon Symposium, [SL] Satellite Symposium, [OP] Oral Presentation, [PD] Poster Discussion
| Sep.2 (WED) | Date | Sep.3 (THU) | ||||
|---|---|---|---|---|---|---|
| Room D | Time | Room A | Room B | Room C | Room D | Room E |
| 08:30-10:00 |
JS01 ASCO/KSMO |
JS02 KCSG/KSMO (08:30-09:50) |
SS01 | ES01 |
SL01 (8:30-9:10) |
|
|
SL02 (9:20-10:00) |
||||||
| Break (20 min.) | ||||||
| 10:00-10:10 | Break (10 min.) | Break (10 min.) | ||||
| 10:10-10:30 | Opening Ceremony | |||||
| 10:30-11:10 | PL01 | |||||
| 11:10-11:20 | Break (10 min.) | |||||
| 11:20-12:00 |
LS01 |
LS02 |
LS03 |
LS04 |
LS05 |
|
| 12:00-12:10 | Break (10 min.) | |||||
| 12:10-13:40 | SS02 (12:10-13:30) |
JS03 KOSRO/KSMO |
SS03 (12:10-13:30) |
ES02 |
SL03 (12:10-12:50) |
|
|
SP01 (12:20-13:50) |
||||||
|
SL04 (13:00-13:40) |
||||||
| Break (20 min.) | Break (20 min.) | |||||
| 13:40-13:50 | Break (10 min.) | Break (10 min.) | ||||
| Break (15 min.) |
13:50-15:20 | JS04 ESMO/KSMO |
OP01 (13:50-14:50) |
SS04 (13:50-15:10) |
ES03 (13:50-15:10) |
SL05 (13:50-14:30) |
|
SP02 (14:05-16:05) |
||||||
|
SL06 (14:30-15:10) |
||||||
| PD01 (14:50-15:20) |
||||||
| Break (20 min.) | ||||||
| 15:20-15:30 | Break (10 min.) | |||||
| 15:30-16:10 |
PL02 (15:30-16:10) |
|||||
| Break (15 min.) |
16:10-17:40 | SS05 | JS05 KSSO/KSMO |
SS06 | JS06 KSR/KSMO |
SL07 (16:10-16:50) |
|
SP03 (16:20-17:50) |
||||||
|
SL08 (17:00-17:40) |
||||||
| 17:40-17:50 | ||||||
| Break (10 min.) | 17:50-18:00 | |||||
|
Welcome Reception (18:00-) |
18:00~ | |||||
| Date | Sep.4 (FRI) | ||||
|---|---|---|---|---|---|
| Time | Room A | Room B | Room C | Room D | Room E |
| 08:30-10:00 |
JS07 JSMO/KSMO |
JS08
KSP/KSMO |
MDCD (08:30-09:50) |
ES04 |
SL09 (8:30-9:10) |
|
SL10 (9:20-10:00) |
|||||
| Break (30 min.) | |||||
| 10:00-10:20 | Break (20 min.) |
Break (20 min.) | |||
| 10:20-11:00 |
PL03 (10:20-11:00) |
||||
| 11:00-11:20 | Break (20 min.) |
||||
| 11:20-12:00 |
LS06 |
LS07 |
LS08 |
LS09 |
LS10 |
| 12:00-12:10 | Break (10 min.) | ||||
| 12:10-13:40 | JS09 ASCO/KSMO |
SS07 |
SS08 | FACO 1 (12:10-13:30) |
SL11 (12:10-12:50) |
|
SL12 (12:50-13:30) |
|||||
| Break (20 min.) | |||||
| 13:40-13:50 | Break (10 min.) | ||||
| 13:50-14:30 | PL04 (13:50-14:30) |
||||
| 14:30-14:40 | Break (10 min.) | ||||
| 14:40-16:10 | JS10 ESMO/KSMO |
OP02 (14:40-15:40) |
SS09 (14:40-16:00) |
FACO 2 (14:40-16:00) |
SL13 (14:40-15:20) |
|
SL14 (15:30-16:10) |
|||||
| PD02 (15:40-16:10) |
|||||
| Break (10 min.) | |||||
| 16:10-16:30 | Closing Ceremony (16:10-16:30) |
||||
| Date | Sep.2 (WED) |
|---|---|
| Time | Room D |
| 12:20-13:50 |
SP01 Past, present and future of precision oncology clinical trials: Legacy of KOSMOS trial |
| 13:50-14:05 | Break (15 min.) |
| 14:05-16:05 | SP02 |
| 16:05-16:20 | Break (15 min.) |
| 16:20-17:50 |
SP03 Artificial intelligence in medical oncology: Learning from clinics, images, and tissue |
| 17:50-18:00 | Break (10 min.) |
| 18:00~ | Welcome Reception |
| Date | Sep.3 (THU) | ||||
|---|---|---|---|---|---|
| Time | Room A | Room B | Room C | Room D | Room E |
| 08:30-10:00 |
JS01 ASCO/KSMO How neoadjuvant therapy is redefining the surgeon-oncologist partnership |
JS02 KCSG/KSMO (08:30-09:50) Maximizing cure in early stage-cancer |
SS01 Scientific breakthroughs in palliative oncology: Evidence-based symptom science |
ES01 Real-world geriatric oncology: Transition from research to practice KOR |
SL01 (8:30-9:10) |
|
SL02 (9:20-10:00) |
|||||
| Break (20 min.) | |||||
| 10:00-10:10 | Break (10 min.) | Break (10 min.) | |||
| 10:10-10:30 | Opening Ceremony | ||||
| 10:30-11:10 |
PL01 New concepts in cancer biology: From the microbiome to non-coding DNA |
||||
| 11:10-11:20 | Break (10 min.) | ||||
| 11:20-12:00 |
LS01 |
LS02 |
LS03 |
LS04 |
LS05 |
| 12:00-12:10 | Break (10 min.) | ||||
| 12:10-13:40 |
SS02 (12:10-13:30) Integrating advanced systemic therapies for localizd gastrointestinal cancers: Transforming palliation into cure |
JS03 KOSRO/KSMO Refining management of central nervous system tumors |
SS03 (12:10-13:30) Tissue-agnostic oncology in rare cancers : When biology outgrows histology |
ES02 ctDNA in the clinic: Evidence, interpretation, and real-world decisions KOR |
SL03 (12:10-12:50) |
|
SL04 (13:00-13:40) |
|||||
| Break (20 min.) | Break (20 min.) | ||||
| 13:40-13:50 | Break (10 min.) | Break (10 min.) | |||
| 13:50-15:20 |
JS04 ESMO/KSMO Implementation of AI in cancer care |
OP01 (13:50-14:50) |
SS04 (13:50-15:10) Evolving standards of care in GU malignancies |
ES03 (13:50-15:10) From bench to clinic: Recent advance of ADC and BiTE in precision oncology KOR |
SL05 (13:50-14:30) |
|
SL06 (14:30-15:10) |
|||||
| PD01 (14:50-15:20) |
|||||
| Break (20 min.) | |||||
| 15:20-15:30 | Break (10 min.) | ||||
| 15:30-16:10 |
PL02 RAS: What have we learned, what are we learning, what do we need to learn! |
||||
| 16:10-17:40 |
SS05 Biomarker-driven precision oncology in breast cancer |
JS05 KSSO/KSMO Clinical applications of ctDNA for minimal residual disease across solid tumors |
SS06 Novel opportunities to target cancer: Emerging strategies in molecular oncology |
JS06 KSR/KSMO Quantitative imaging biomarkers for precision oncology |
SL07 (16:10-16:50) |
|
SL08 (17:00-17:40) |
|||||
| 17:40-17:50 | |||||
| Date | Sep.4 (FRI) | ||||
|---|---|---|---|---|---|
| Time | Room A | Room B | Room C | Room D | Room E |
| 08:30-10:00 |
JS07 JSMO/KSMO From evidence to practice; The rise of chemo-IO combination in the perioperative setting |
JS08
KSP/KSMO Integrating digital pathology and spatial biology: Emerging insights for precision oncology |
MDCD
(08:30-09:50) Integrated multidisciplinary strategies in lung cancer care: Lessons from real-world cases KOR |
ES04 Experimental technology for precision medicine KOR |
SL09 (8:30-9:10) |
|
SL10 (9:20-10:00) |
|||||
| Break (30 min.) | |||||
| 10:00-10:20 | Break (20 min.) | Break (20 min.) | |||
| 10:20-11:00 |
PL03 ctDNA and minimal residual disease in colorectal cancer: Evidence, challenges and the road ahead (Tentative) |
||||
| 11:00-11:20 | Break (20 min.) | ||||
| 11:20-12:00 |
LS06 |
LS07 |
LS08 |
LS09 |
LS10 |
| 12:00-12:10 | Break (10 min.) | ||||
| 12:10-13:40 |
JS09 ASCO/KSMO From data to decisions: AI and real-world evidence transforming oncology practice |
SS07 Evolving targeted therapies for gastrointestinal cancers: Navigating new frontiers beyond established standards |
SS08 The evolving landscape of cell-based and engager therapies for solid cancers |
FACO 1 |
SL11 (12:10-12:50) |
|
SL12 (12:50-13:30) |
|||||
| Break (20 min.) | |||||
| 13:40-13:50 | Break (10 min.) | ||||
| 13:50-14:30 |
PL04 Encouraging results and updates on personalized cancer vaccines |
||||
| 14:30-14:40 | Break (10 min.) | ||||
| 14:40-16:10 |
JS10 ESMO/KSMO ESMO guidelines on the management of breast cancer |
OP02 (14:40-15:40) |
SS09 (14:40-16:00) State of the art therapy and future direction of EGFR-Mutant NSCLC |
FACO 2 (14:40-16:00) |
SL13 (14:40-15:20) |
|
SL14 (15:30-16:10) |
|||||
| PD02 (15:40-16:10) |
|||||
| Break (10 min.) | |||||
| 16:10-16:30 | Closing Ceremony (16:10-16:30) |
||||